Classification of adrenal cortical tumors: What limits for the pathological approach?

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 6, 2010, Pages 877-885

  Tissier, Frédérique ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Adrenal; Adrenal cortex; Adrenocortical adenoma; Adrenocortical carcinoma; Adrenocortical tumor; Cyclin E; IGF II; Immunohistochemistry; Ki 67; P53; Wnt catenin signaling pathway

Indexed keywords

BETA CATENIN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; CYCLIN E; CYTOKERATIN; GLYPICAN 3; INHIBIN A; KI 67 ANTIGEN; MELAN A; PROTEIN P53; SOMATOMEDIN B; STEROIDOGENIC FACTOR 1; SYNAPTOPHYSIN; TUMOR MARKER; VIMENTIN;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; CANCER CLASSIFICATION; CELL DEATH; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; PHEOCHROMOCYTOMA; PROGNOSIS; REVIEW; WEISS SCORING SYSTEM;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ANIMALS; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649676134     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.10.011     Document Type: Review

References (70)

1. L.R. DeLellis Ra, P.U. Heitz, and C. Eng Pathology and genetics. Tumors of endocrine organs. World Health Organization classification of tumors 2004
2. M. Terzolo, A. Angeli, and M. Fassnacht Adjuvant mitotane treatment for adrenocortical carcinoma New England Journal of Medicine 356 2007 2372 2380
3. L.S. Kirschner Emerging treatment strategies for adrenocortical carcinoma: a new hope Journal of Clinical Endocrinology and Metabolism 91 2006 14 21
4. L. Groussin, J. Bertherat, and C. Gicquel Insights into the molecular biology of adrenocortical tumors Experimental and Clinical Endocrinology and Diabetes 115 2007 175 178
5. F. Tissier [Pathology of adrenocortical tumors: review and recent data] Annales d'Endocrinologie 70 2009 179 185
6. S. Aubert, D. Buob, and X. Leroy [Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy] Annales de Pathologie 25 2005 545 554
7. T.J. Giordano Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas Endocrine Pathology 17 2006 355 363
8. W.F. Young Primary aldosteronism: renaissance of a syndrome Clinical Endocrinology 66 2007 607 618
9. E.E. Lack Tumors of the adrenal gland and extra-adrenal paraganglia. Atlas of tumor pathology 1995 Washington, DC
10. A.M. McNicol Lesions of the adrenal cortex Archives of Pathology and Laboratory Medicine 132 2008 1263 1271
11. N.S. Ross, and D.C. Aron Hormonal evaluation of the patient with an incidentally discovered adrenal mass New England Journal of Medicine 323 1990 1401 1405
12. M.P. Hoang, A.G. Ayala, and J. Albores-Saavedra Oncocytic adrenocortical carcinoma: a morphologic, immunohistochemical and ultrastructural study of four cases Modern Pathology 15 2002 973 978
13. B.T. Lin, S.M. Bonsib, and G.W. Mierau Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature American Journal of Surgical Pathology 22 1998 603 614
14. A.K. el-Naggar, D.B. Evans, and B. Mackay Oncocytic adrenal cortical carcinoma Ultrastructural Pathology 15 1991 549 556
15. K. Tanaka, Y. Kumano, and N. Kanomata Oncocytic adrenocortical carcinoma Urology 64 2004 376 377
16. M. Bisceglia, O. Ludovico, and A. Di Mattia Adrenocortical oncocytic tumors: report of 10 cases and review of the literature International Journal of Surgical Pathology 12 2004 231 243
17. N. Sturm, N. Moulai, and M.H. Laverriere Primary adrenocortical sarcomatoid carcinoma: case report and review of literature Virchows Archiv 452 2008 215 219
18. M.S. Lee, I.A. Park, and J.G. Chi Adrenal carcinosarcoma-a case report Journal of Korean Medical Science 12 1997 374 377
19. J.W. Decorato, H. Gruber, and M. Petti Adrenal carcinosarcoma Journal of Surgical Oncology 45 1990 134 136
20. D.F. Fischler, C. Nunez, and H.S. Levin Adrenal carcinosarcoma presenting in a woman with clinical signs of virilization. A case report with immunohistochemical and ultrastructural findings American Journal of Surgical Pathology 16 1992 626 631
21. P. Komminoth, J. Roth, and S. Schroder Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors Laboratory Investigation 72 1995 424 431
22. R.J. Cote, C. Cordon-Cardo, and V.E. Reuter Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex American Journal of Pathology 136 1990 1077 1084
23. M. Volante, C. Buttigliero, and E. Greco Pathological and molecular features of adrenocortical carcinoma: an update Journal of Clinical Pathology 61 2008 787 793
24. M.J. Gaffey, S.T. Traweek, and S.E. Mills Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma Human Pathology 23 1992 144 153
25. S. Schroder, B.C. Padberg, and E. Achilles Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms Virchows Archiv A, Pathological Anatomy and Histopathology 420 1992 65 70
26. T.S. Loy, R.W. Phillips, and C.L. Linder A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases Archives of Pathology and Laboratory Medicine 126 2002 170 172
27. K.J. Busam, Y.T. Chen, and L.J. Old Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma American Journal of Surgical Pathology 22 1998 976 982
28. Z. Ghorab, M. Jorda, and P. Ganjei (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas Applied Immunohistochemistry and Molecular Morphology 11 2003 330 333
29. K.J. Busam, K. Iversen, and K.A. Coplan Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors American Journal of Surgical Pathology 22 1998 57 63
30. C.C. Pan, P.C. Chen, and S.H. Tsay Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma: a systemic immunohistochemical survey using tissue array technique Applied Immunohistochemistry and Molecular Morphology 13 2005 347 352
31. J. Arola, J. Liu, and P. Heikkila Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm Journal of Endocrinology 165 2000 223 229
32. P.A. Fetsch, C.N. Powers, and M.F. Zakowski Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration Cancer 87 1999 168 172
33. K. Shigematsu, N. Nishida, and H. Sakai Synaptophysin immunoreactivity in adrenocortical adenomas: a correlation between synaptophysin and CYP17A1 expression European Journal of Endocrinology 161 2009 939 945
34. H. Sasano, S. Shizawa, and T. Suzuki Ad4BP in the human adrenal cortex and its disorders Journal of Clinical Endocrinology and Metabolism 80 1995 2378 2380
35. H. Sasano, S. Shizawa, and T. Suzuki Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy Human Pathology 26 1995 1154 1156
36. M. Jorda, M.B. De, and M. Nadji Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas Applied Immunohistochemistry and Molecular Morphology 10 2002 67 70
37. D.H. Kandil, and K. Cooper Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more Advances in Anatomic Pathology 16 2009 125 129
38. V. Varma, and C. Cohen Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma Advances in Anatomic Pathology 11 2004 239 249
39. L.M. Weiss Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors American Journal of Surgical Pathology 8 1984 163 169
40. H. van Slooten, A. Schaberg, and D. Smeenk Morphologic characteristics of benign and malignant adrenocortical tumors Cancer 55 1985 766 773
41. A.J. Hough, J.W. Hollifield, and D.L. Page Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data American Journal of Clinical Pathology 72 1979 390 399
42. S.K. Lau, and L.M. Weiss The Weiss system for evaluating adrenocortical neoplasms: 25 years later Human Pathology 40 2009 757 768
43. S. Aubert, A. Wacrenier, and X. Leroy Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors American Journal of Surgical Pathology 26 2002 1612 1619
44. A.M. McNicol, A.L. Struthers, and C.E. Nolan Proliferation in adrenocortical tumors: correlation with clinical outcome and p53 status Endocrine Pathology 8 1997 29 36
45. H. Nakazumi, H. Sasano, and K. Iino Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms Modern Pathology 11 1998 1165 1170
46. M. Terzolo, A. Boccuzzi, and S. Bovio Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors Urology 57 2001 176 182
47. S. Kiiveri, J. Liu, and J. Arola Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors Molecular and Cellular Endocrinology 233 2005 47 56
48. J. Arola, K. Salmenkivi, and J. Liu p53 and Ki67 in adrenocortical tumors Endocrine Research 26 2000 861 865
49. G.P. Bernini, A. Moretti, and P. Viacava Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues British Journal of Cancer 86 2002 1561 1565
50. C. Wachenfeld, F. Beuschlein, and O. Zwermann Discerning malignancy in adrenocortical tumors: are molecular markers useful? European Journal of Endocrinology 145 2001 335 341
51. A. Stojadinovic, M.F. Brennan, and A. Hoos Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis Modern Pathology 16 2003 742 751
52. R. Morimoto, F. Satoh, and O. Murakami Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas Endocrine Journal 55 2008 49 55
53. R. Libe, A. Fratticci, and J. Bertherat Adrenocortical cancer: pathophysiology and clinical management Endocrine Related Cancer 14 2007 13 28
54. R. Libe, and J. Bertherat Molecular genetics of adrenocortical tumours, from familial to sporadic diseases European Journal of Endocrinology 153 2005 477 487
55. M. Reincke, C. Wachenfeld, and P. Mora p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan Journal of Clinical Endocrinology and Metabolism 81 1996 3636 3638
56. A. Schmitt, P. Saremaslani, and S. Schmid IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours Histopathology 49 2006 298 307
57. A.M. McNicol, C.E. Nolan, and A.J. Struthers Expression of p53 in adrenocortical tumours: clinicopathological correlations Journal of Pathology 181 1997 146 152
58. L. Barzon, M. Chilosi, and F. Fallo Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors European Journal of Endocrinology 145 2001 207 212
59. R. Libe, L. Groussin, and F. Tissier Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity Clinical Cancer Research 13 2007 844 850
60. F. Wilkin, N. Gagne, and J. Paquette Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression Journal of Clinical Endocrinology and Metabolism 85 2000 2048 2056
61. N. Bourcigaux, V. Gaston, and A. Logie High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors Journal of Clinical Endocrinology and Metabolism 85 2000 322 330
62. F. Tissier, A. Louvel, and S. Grabar Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors European Journal of Endocrinology 150 2004 809 817
63. F. Tissier, C. Cavard, and L. Groussin Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors Cancer Research 65 2005 7622 7627
64. S. Gaujoux, F. Tissier, and L. Groussin Wnt/beta-catenin and 3′5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors Journal of Clinical Endocrinology and Metabolism 93 2008 4135 4140
65. L.M. Weiss, L.J. Medeiros, and A.L. Vickery Jr. Pathologic features of prognostic significance in adrenocortical carcinoma American Journal of Surgical Pathology 13 1989 202 206
66. M. Wagner, P.R. Walter, and J.P. Ghnassia [Adrenocortical tumors. I. Prognostic evaluation of a series of 17 cases using the Weiss criteria] Annales de Pathologie 13 1993 306 311
67. C. Gicquel, X. Bertagna, and V. Gaston Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors Cancer Research 61 2001 6762 6767
68. C. Pohlink, A. Tannapfe, and U. Eichfeld Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors? Journal of Endocrinological Investigation 27 2004 565 569
69. H.P. van't Sant, N.D. Bouvy, and G. Kazemier The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas Histopathology 51 2007 239 245
70. S.A. Fuhrman, L.C. Lasky, and C. Limas Prognostic significance of morphologic parameters in renal cell carcinoma American Journal of Surgical Pathology 6 1982 655 663